Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kadar Moideen

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Frontiers in Nutrition|November 26, 2025
Altered serum mineral concentrations among pulmonary tuberculosis and its association with Vitamin D, adipokines and inflammatory cytokinesKadar Moideen, Harinisri Gunasekaran, Bidyalakshmi Loukrakpam, et al.
BMC Infectious Diseases|July 27, 2018
Elevated levels of matrix metalloproteinases reflect severity and extent of disease in tuberculosis-diabetes co-morbidity and are predominantly reversed following standard anti-tuberculosis or metformin treatmentNathella P Kumar, Kadar Moideen, Vijay Viswanathan, et al.
Frontiers in Immunology|March 29, 2020
Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Are Potential Biomarkers of Pulmonary and Extra-Pulmonary TuberculosisGokul Raj Kathamuthu, Nathella Pavan Kumar, Kadar Moideen, et al.
Cytokine|June 7, 2018
Diminished circulating plasma and elevated lymph node culture supernatant levels of IL-10 family cytokines in tuberculous lymphadenitisGokul Raj Kathamuthu, Nathella Pavan Kumar, Kadar Moideen, et al.
Frontiers in Immunology|December 6, 2021
Acute Phase Proteins Are Baseline Predictors of Tuberculosis Treatment FailureNathella Pavan Kumar, Kadar Moideen, Arul Nancy, et al.
Immunology|June 23, 2015
Profiling leucocyte subsets in tuberculosis-diabetes co-morbidityNathella Pavan Kumar, Kadar Moideen, Sharmila D Dhakshinraj, et al.
BMC Infectious Diseases|December 11, 2019
Systemic RAGE ligands are upregulated in tuberculosis individuals with diabetes co-morbidity and modulated by anti-tuberculosis treatment and metformin therapyNathella Pavan Kumar, Kadar Moideen, Arul Nancy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 30, 2022
Heightened Microbial Translocation Is a Prognostic Biomarker of Recurrent TuberculosisNathella Pavan Kumar, Kadar Moideen, Vijay Viswanathan, et al.
Frontiers in Cellular and Infection Microbiology|October 22, 2019
Plasma Eicosanoid Levels in Tuberculosis and Tuberculosis-Diabetes Co-morbidity Are Associated With Lung Pathology and Bacterial BurdenNathella Pavan Kumar, Kadar Moideen, Arul Nancy, et al.
Scientific Reports|December 5, 2019
Plasma chemokines are biomarkers of disease severity, higher bacterial burden and delayed sputum culture conversion in pulmonary tuberculosisNathella P Kumar, Kadar Moideen, Arul Nancy, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Frontiers in Nutrition|November 26, 2025
Altered serum mineral concentrations among pulmonary tuberculosis and its association with Vitamin D, adipokines and inflammatory cytokinesKadar Moideen, Harinisri Gunasekaran, Bidyalakshmi Loukrakpam, et al.
BMC Infectious Diseases|July 27, 2018
Elevated levels of matrix metalloproteinases reflect severity and extent of disease in tuberculosis-diabetes co-morbidity and are predominantly reversed following standard anti-tuberculosis or metformin treatmentNathella P Kumar, Kadar Moideen, Vijay Viswanathan, et al.
Frontiers in Immunology|March 29, 2020
Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Are Potential Biomarkers of Pulmonary and Extra-Pulmonary TuberculosisGokul Raj Kathamuthu, Nathella Pavan Kumar, Kadar Moideen, et al.
Cytokine|June 7, 2018
Diminished circulating plasma and elevated lymph node culture supernatant levels of IL-10 family cytokines in tuberculous lymphadenitisGokul Raj Kathamuthu, Nathella Pavan Kumar, Kadar Moideen, et al.
Frontiers in Immunology|December 6, 2021
Acute Phase Proteins Are Baseline Predictors of Tuberculosis Treatment FailureNathella Pavan Kumar, Kadar Moideen, Arul Nancy, et al.
Immunology|June 23, 2015
Profiling leucocyte subsets in tuberculosis-diabetes co-morbidityNathella Pavan Kumar, Kadar Moideen, Sharmila D Dhakshinraj, et al.
BMC Infectious Diseases|December 11, 2019
Systemic RAGE ligands are upregulated in tuberculosis individuals with diabetes co-morbidity and modulated by anti-tuberculosis treatment and metformin therapyNathella Pavan Kumar, Kadar Moideen, Arul Nancy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 30, 2022
Heightened Microbial Translocation Is a Prognostic Biomarker of Recurrent TuberculosisNathella Pavan Kumar, Kadar Moideen, Vijay Viswanathan, et al.
Frontiers in Cellular and Infection Microbiology|October 22, 2019
Plasma Eicosanoid Levels in Tuberculosis and Tuberculosis-Diabetes Co-morbidity Are Associated With Lung Pathology and Bacterial BurdenNathella Pavan Kumar, Kadar Moideen, Arul Nancy, et al.
Scientific Reports|December 5, 2019
Plasma chemokines are biomarkers of disease severity, higher bacterial burden and delayed sputum culture conversion in pulmonary tuberculosisNathella P Kumar, Kadar Moideen, Arul Nancy, et al.
Pageof 6